Polaris Market Research today announced findings from its latest report, projecting the global Ewing sarcoma therapeutics market to grow from USD 245.66 million in 2022 to USD 424.42 million by 2032, at a CAGR of 5.7%. The report profiles fourteen leading companies across four segment groups and examines how pipeline medications, advances in disease detection and rising healthcare spending are...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek